Bio-IT World July 12, 2019
With engineering as his background, John-William Sidhom, a MD and PhD Candidate at the Bloomberg-Kimmel Institute for Cancer Immunotherapy at Johns Hopkins, says the ideal scenario would be to have a system where scientific research asks the relevant questions, tech provides answers to those questions, and the physician implements those solutions for the most clinical impact.
“The goal is to have these three dimensions where the engineering aspect brings in this computational ability to solve problems very creatively,” he says. “As a scientist, I’m able to ask the most relevant questions and the most insightful ones, and then as a clinician, being able to really translate those findings into something that’s clinically beneficial for patients and their family [is...